Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18085206 | 0.96 | ESR1 (0.48) | ESR1HPGDALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL21874407 | 0.89 | CYP2A6 (0.50) | ESR1HPGDALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL13417802 | 0.83 | CYP2A6 (0.44) | HPGDALDH1A1CYP3A4HSD17B10NPC1 | |
| SCHEMBL15566288 | 0.81 | ALDH1A1 (0.47) | HPGDALDH1A1CYP3A4HSD17B10NPC1 | |
| SCHEMBL21503905 | 0.81 | ALDH1A1 (0.47) | HPGDALDH1A1CYP3A4HSD17B10NPC1 | |
| SCHEMBL14339277 | 0.81 | ALDH1A1 (0.47) | HPGDALDH1A1CYP3A4HSD17B10NPC1 | |
| SCHEMBL14339280 | 0.81 | ALDH1A1 (0.47) | HPGDALDH1A1CYP3A4HSD17B10NPC1 | |
| SCHEMBL31212637 | 0.81 | ALDH1A1 (0.47) | HPGDALDH1A1CYP3A4HSD17B10NPC1 | |
| SCHEMBL30544386 | 0.81 | ALDH1A1 (0.47) | HPGDALDH1A1CYP3A4HSD17B10NPC1 | |
| SCHEMBL14339279 | 0.81 | ALDH1A1 (0.47) | HPGDALDH1A1CYP3A4HSD17B10NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019198806-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | 出光興産株式会社 | 2019-10-17 | — | — | WO | disclosed |
| US-20160240793-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | LG CHEM, LTD. (KR) | 2016-08-18 | — | — | US | disclosed |
| US-20160233431-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | LG CHEM, LTD. (KR) | 2016-08-11 | — | — | US | disclosed |
| US-20160233432-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | LG CHEM, LTD. (KR) | 2016-08-11 | — | — | US | disclosed |
| US-5068425-A | Nervous system disorders, intermediates for drugs and as enantiomorphs | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1991-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160240793-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CRY1, CRY2, NR2E3 | ESR1 19/4885HPGD 1235/4885ALDH1A1 252/4885 |
| US-20160233431-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CRY1, CRY2, NR2E3 | ESR1 19/4885HPGD 1235/4885ALDH1A1 252/4885 |
| US-20160233432-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CRY1, CRY2, NR2E3 | ESR1 19/4885HPGD 1235/4885ALDH1A1 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.